期刊文献+

斑块状银屑病表皮干扰素-γ受体mRNA表达的研究

The mRNA expression of IFN-gamma receptor in epidermis of patients with plaque psoriasis
原文传递
导出
摘要 目的 探讨斑块状银屑病患者表皮干扰素-γ受体mRNA的表达及其在发病机制中的作用。方法 采集28例斑块状银屑病患者皮损及周围外观正常皮肤。28例正常人皮肤作为对照,分离表皮,逆转录聚合酶链反应(RT-PCR)法检测干扰素-γ受体mRNA表达水平。PASI评分法评估银屑病的严重程度。结果 斑块状银屑病患者皮损和非皮损表皮干扰素-γ受体mRNA的表达率为100%,对照样本的表达率为17.86%(5/28);患者皮损、非皮损和对照表皮干扰素-γ受体mRNA的表达水平均值分别为1.002±0.563、0.188±0、095、0.005±0.012,皮损处的表达水平明显高于非皮损处(t=7.54,P〈0、01)。非皮损处明显高于正常人对照;进行期与稳定期皮损的表达水平分别为1、210±0.489和0.379±0.163,进行期显著高于稳定期(t=4.37,P〈0.01);而皮损处的表达水平与PASI评分值无相关性。结论 表皮干扰素-γ受体mRNA的表达可能与银屑病皮损的形成和病情的活动性有关。 Objective To explore the-mRNA expression of IFN-gamma receptor in epidermis of patients with plaque psoriasis and its role in the pathogenesis of psoriasis. Methods Lesional and non-lesional specimens were obtained from psoriatic patients ( n = 28 ) and normal controls ( n = 28 ). Epidermis was detached, and subjected to reverse transcriptase polymerase chain reaction (RT-PCR) for the measurement of IFN-gamma receptor mRNA. The disease severity was evaluated by psoriasis area and severity index (PASI). Results The IFN-gamma receptor mRNA was expressed in all lesional and non-lesional epidermis from the patients, while in only 17.86% ( 5/28 ) from controls. The mean value of IFN-gamma receptor mRNA in the lesional epidermis was significantly higher than that in the non-lesional epidermis ( 1.002±0.563 vs 0.188 ± 0.095, t = 7.54, P 〈 0.01 ), and the latter was significantly elevated compared with the controls ( 0.188 ± 0.095 vs 0.005 ± 0.012, t= 10.17, P〈 0.01 ). The expression level of IFN-gamma receptor mRNA was significantly higher in active lesions than in stable lesions ( 1.210 ± 0.489 vs 0.379 ± 0.163, t= 4.37, P〈 0.01 ). However, no correlation was found between the expression levels of IFN-gamma receptor mRNA and disease severity. Conclusions The mRNA expression of IFN-gamma receptor may be related to the lesion formation and disease severity in psoriatic patients.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2007年第3期146-148,共3页 Chinese Journal of Dermatology
基金 江苏省人事厅“六大人才高峰”项目资助,江苏省自然科学基金部分资助(BK2001195),国家自然科学基金部分资助(30170863)
关键词 银屑病 受体 干扰素 Psoriasis Receptor, interferon
  • 相关文献

参考文献5

二级参考文献16

  • 1Fossiez F, Djossou O,Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med, 1996, 183: 2593-2603.
  • 2Teunissen MB, Koomen CW, de Waal Malefyt R, et al. Interleukin17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol, 1998, 111: 645-649.
  • 3Dieu-Nosjean MC, Massacrier C, Homey B, et al. Macrophage inflammatory protein 3 alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med, 2000, 192: 705-718.
  • 4Homey B, Dieu-Nosjean MC, Wiesenborn A, et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol, 2000, 164: 6621-6632.
  • 5Chabaud M,Page G, Miossec P.Enhancing effect of IL-1, IL-17,and TNF-alpha on macrophage inflammatory protein-3 alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol, 2001, 167: 6015-6020.
  • 6Austin LM,Ozawa M, Kikuchi T,et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines,interferon-gamma, interleukin-2, and tumor necrosis factor-alpha,defining TC1 (cytotoxic T lymphocyte) and TH1 effector popula
  • 7Nishibu A, Han GW, Iwatsuki K,et al. Overexpression of monocyte-derived cytokines in active psoriasis: a relation to coexistent arthropathy. J Dermatol Sci, 1999, 21: 63-70.
  • 8Aggarwal S, Ghilardi N, Xie MH,et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem, 2003, 278: 1910-1914.
  • 9Barker JN.Psoriasis as a T cell-mediated autoimmune disease.Hosp Med,1998,59:530-533.
  • 10Gudmundsdottir AS,Sigmundsdottir H,Sigurgeirsson B,et al.Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis? Clin Exp Immunol,1999,117:580-586.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部